Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section

Marco V. Corniola, Pierre-Hugues Roche, Michaël Bruneau, Luigi Cavallo, Roy T Daniel, Mahmoud Messerer, Sebastien Froelich, Paul A. Gardner, Fred Gentili, T Kawase, Dimitrios Paraskevopoulos, Jean Régis, Henry W S Schroeder, Theodore H. Schwartz, M Sindou, JF Cornelius, Marcos Tatagiba, Torstein R Meling

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy of
their treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneity
of classifications and lack of randomized controlled trials. Here, a dedicated task force provides a
consensus statement on the overall management of CSMs.
Research question: To determine the best overall management of CSMs, depending on their clinical presentation,
size, and evolution as well as patient characteristics.
Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December
2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.
Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highly
specialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinological
and radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeons
or neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.
Original languageEnglish
Article number100864
Number of pages16
JournalBrain and spine
Publication statusPublished - 21 Jan 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors

Copyright 2023 Elsevier B.V., All rights reserved.

Cite this